ProPhase Labs, Inc. (PRPH) Director Sells $10,071.70 in Stock
ProPhase Labs, Inc. (NASDAQ:PRPH) Director Jason Michael Barr sold 4,379 shares of the firm’s stock in a transaction that occurred on Friday, September 29th. The shares were sold at an average price of $2.30, for a total transaction of $10,071.70. Following the completion of the sale, the director now owns 7,721 shares in the company, valued at $17,758.30. The transaction was disclosed in a document filed with the SEC, which is available at this link.
ProPhase Labs, Inc. (NASDAQ:PRPH) traded up 2.44% during midday trading on Thursday, reaching $2.10. 1,969 shares of the company traded hands. The stock’s 50 day moving average is $2.22 and its 200 day moving average is $2.08. The company has a market capitalization of $33.95 million, a price-to-earnings ratio of 0.87 and a beta of 0.02. ProPhase Labs, Inc. has a one year low of $1.78 and a one year high of $2.45.
ProPhase Labs (NASDAQ:PRPH) last issued its quarterly earnings results on Friday, August 11th. The company reported ($0.09) EPS for the quarter. ProPhase Labs had a net margin of 270.98% and a return on equity of 54.87%. The business had revenue of $1.91 million for the quarter.
ProPhase Labs declared that its Board of Directors has approved a share repurchase plan on Tuesday, August 15th that allows the company to buyback 4,000,000 outstanding shares. This buyback authorization allows the company to purchase shares of its stock through a tender offer. Stock buyback plans are typically a sign that the company’s board of directors believes its shares are undervalued.
Separately, ValuEngine downgraded shares of ProPhase Labs from a “hold” rating to a “sell” rating in a research report on Thursday.
ProPhase Labs Company Profile
ProPhase Labs, Inc manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company’s products include TK Supplements and ORXx Complete.
Receive News & Ratings for ProPhase Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProPhase Labs Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.